A Phase 1 Pharmacokinetic Study To Compare the Relative Bioavailability of Two Clinical Formulations of Linifanib in Subjects With Solid Tumours.
Latest Information Update: 19 Oct 2015
At a glance
- Drugs Linifanib (Primary)
- Indications Solid tumours
- Focus Pharmacokinetics
- Sponsors Abbott Laboratories
- 21 Mar 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 29 Jun 2011 New trial record